Control of Medulloblastoma Migration & Survival by Unc5c
控制髓母细胞瘤迁移
基本信息
- 批准号:7150352
- 负责人:
- 金额:$ 33.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-06-01 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Medulloblastoma is the most common malignant brain tumor in children. Its rapid growth and tendency to spread through the nervous system make it extremely difficult to treat, and more than 40% of the children who develop the disease die from it. Improved treatment of medulloblastoma is likely to come from a deeper understanding of the signals that control normal cerebellar development, and an appreciation of how these signals are dysregulated in tumors. To identify such signals, we have studied an animal model of medulloblastoma - the patched mutant mouse - and identified genes whose expression is altered in tumor cells compared to granule cell precursors (GCPs), the cells from which the tumor is believed to arise. Among the genes whose expression decreased most significantly was Unc5c, which encodes a receptor for the netrin family of signaling molecules. Unc5c was originally described as a regulator of cell migration, but has recently been shown to play an important role in apoptosis as well. Moreover, Unc5c is deleted or mutated in a variety of cancers, and has therefore been suggested to function as a tumor suppressor. We hypothesize that Unc5c controls migration and survival of GCPs during normal cerebellar development, and that its loss contributes to the abnormal migration and increased survival observed in medulloblastoma. If this hypothesis is correct, it will have important implications for our understanding of medulloblastoma, and open up new avenues for treatment of the disease. To test our hypothesis, we propose to: 1) Determine whether Unc5c regulates inward migration of granule cell precursors and tumor cells 2) Test whether Unc5c regulates survival of granule cell precursors and tumor cells 3) Determine whether loss of Unc5c is required for medulloblastoma formation Relevance to Public Health: One of the greatest challenges in medulloblastoma treatment is the ability of tumor cells to migrate into regions where they would not normally go, and to survive once they get there. Our observation of altered Unc5c expression in medulloblastoma is significant because it can contribute to both of these behaviors. By elucidating the role of Unc5c in migration and survival, our studies will shed light on the molecular mechanisms that underlie the aggressive growth and dissemination of medulloblastoma. This, in turn, will pave the way for developing new treatments that can be used to fight this devastating disease.
描述(由申请人提供):髓母细胞瘤是儿童中最常见的恶性脑肿瘤。神经管母细胞瘤是一种神经系统疾病,它的生长速度快,易于通过神经系统扩散,因此治疗非常困难,超过40%的儿童死于这种疾病。神经管母细胞瘤的治疗方法的改进可能来自于对控制正常小脑发育的信号的更深入的理解,以及对这些信号在肿瘤中是如何失调的理解。为了识别这些信号,我们研究了髓母细胞瘤的动物模型-补丁突变小鼠-并确定了与颗粒细胞前体(GCPs)相比,肿瘤细胞中表达发生改变的基因,肿瘤被认为是由颗粒细胞前体(GCPs)引起的。其中表达下降最显著的基因是Unc 5c,它编码netrin家族信号分子的受体。Unc 5c最初被描述为细胞迁移的调节剂,但最近已被证明在凋亡中也起重要作用。此外,Unc 5c在多种癌症中缺失或突变,因此被认为是肿瘤抑制因子。我们推测Unc 5c在正常小脑发育过程中控制着GCPs的迁移和存活,其缺失导致了在髓母细胞瘤中观察到的异常迁移和存活增加。如果这一假设是正确的,它将对我们理解髓母细胞瘤有重要意义,并为治疗该病开辟新的途径。为了验证我们的假设,我们建议:1)确定Unc 5c是否调节颗粒细胞前体细胞和肿瘤细胞的向内迁移2)测试Unc 5c是否调节颗粒细胞前体细胞和肿瘤细胞的存活3)确定Unc 5c的缺失是否是髓母细胞瘤形成所必需的。髓母细胞瘤治疗中最大的挑战之一是肿瘤细胞迁移到它们通常不会去的区域的能力,并且一旦它们到达那里就能够存活。我们在髓母细胞瘤中观察到Unc 5c表达的改变是有意义的,因为它可以促进这两种行为。通过阐明Unc 5c在迁移和生存中的作用,我们的研究将揭示髓母细胞瘤侵袭性生长和播散的分子机制。反过来,这将为开发可用于对抗这种毁灭性疾病的新疗法铺平道路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert J. Wechsler-Reya其他文献
RETRACTED ARTICLE: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma
撤回文章:肿瘤坏死因子克服 p53 突变型髓母细胞瘤中的免疫逃避
- DOI:
10.1038/s41593-020-0628-4 - 发表时间:
2020-05-18 - 期刊:
- 影响因子:20.000
- 作者:
Alexandra Garancher;Hiromichi Suzuki;Svasti Haricharan;Lianne Q. Chau;Meher Beigi Masihi;Jessica M. Rusert;Paula S. Norris;Florent Carrette;Megan M. Romero;Sorana A. Morrissy;Patryk Skowron;Florence M. G. Cavalli;Hamza Farooq;Vijay Ramaswamy;Steven J. M. Jones;Richard A. Moore;Andrew J. Mungall;Yussanne Ma;Nina Thiessen;Yisu Li;Alaide Morcavallo;Lin Qi;Mari Kogiso;Yuchen Du;Patricia Baxter;Jacob J. Henderson;John R. Crawford;Michael L. Levy;James M. Olson;Yoon-Jae Cho;Aniruddha J. Deshpande;Xiao-Nan Li;Louis Chesler;Marco A. Marra;Harald Wajant;Oren J. Becher;Linda M. Bradley;Carl F. Ware;Michael D. Taylor;Robert J. Wechsler-Reya - 通讯作者:
Robert J. Wechsler-Reya
Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable emex vivo/em cultures
整合基因组和组织工程技术能够在生理相关的可灌注体外培养物中筛选癌症的脆弱性
- DOI:
10.1016/j.biomaterials.2021.121276 - 发表时间:
2022-01-01 - 期刊:
- 影响因子:12.900
- 作者:
Michael Hu;Xin Yi Lei;Jon D. Larson;Melissa McAlonis;Kyle Ford;Daniella McDonald;Krystal Mach;Jessica M. Rusert;Robert J. Wechsler-Reya;Prashant Mali - 通讯作者:
Prashant Mali
Single-cell mapping identifies MSIsup+/sup cells as a common origin for diverse subtypes of pancreatic cancer
单细胞图谱确定 MSI+/细胞是胰腺癌不同亚型的共同起源
- DOI:
10.1016/j.ccell.2023.09.008 - 发表时间:
2023-11-13 - 期刊:
- 影响因子:44.500
- 作者:
Nirakar Rajbhandari;Michael Hamilton;Cynthia M. Quintero;L. Paige Ferguson;Raymond Fox;Christian M. Schürch;Jun Wang;Mari Nakamura;Nikki K. Lytle;Matthew McDermott;Emily Diaz;Hannah Pettit;Marcie Kritzik;Haiyong Han;Derek Cridebring;Kwun Wah Wen;Susan Tsai;Michael G. Goggins;Andrew M. Lowy;Robert J. Wechsler-Reya;Tannishtha Reya - 通讯作者:
Tannishtha Reya
The transcription factor LHX2 mediates and enhances oncogenic BMP signaling in medulloblastoma
转录因子 LHX2 介导并增强髓母细胞瘤中的致癌性骨形态发生蛋白信号通路。
- DOI:
10.1038/s41418-025-01488-6 - 发表时间:
2025-03-28 - 期刊:
- 影响因子:15.400
- 作者:
Yae Ohata;Mohamad M. Ali;Yutaro Tsubakihara;Yuka Itoh;Gabriela Rosén;Tobias Bergström;Anita Morén;Irene Golán-Cancela;Ayana Nakada;Oleksandr Voytyuk;Maiko Tsuchiya;Rei Fukui;Kouhei Yamamoto;Paula Martín-Rubio;Patricia Sancho;Carina Strell;Patrick Micke;Robert J. Wechsler-Reya;Yoshinobu Hashizume;Kohei Miyazono;Laia Caja;Carl-Henrik Heldin;Fredrik J. Swartling;Aristidis Moustakas - 通讯作者:
Aristidis Moustakas
Robert J. Wechsler-Reya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert J. Wechsler-Reya', 18)}}的其他基金
Identifying and Targeting the Drivers of Pediatric Brain Tumors
识别并针对儿童脑肿瘤的驱动因素
- 批准号:
10708545 - 财政年份:2022
- 资助金额:
$ 33.76万 - 项目类别:
Identifying and Targeting the Drivers of Pediatric Brain Tumors
识别并针对儿童脑肿瘤的驱动因素
- 批准号:
10397691 - 财政年份:2021
- 资助金额:
$ 33.76万 - 项目类别:
Identifying and Targeting the Drivers of Pediatric Brain Tumors
识别并针对儿童脑肿瘤的驱动因素
- 批准号:
10240154 - 财政年份:2021
- 资助金额:
$ 33.76万 - 项目类别:
Regulation of Medulloblastoma Metastasis by Emp1
Emp1 对髓母细胞瘤转移的调节
- 批准号:
9896856 - 财政年份:2016
- 资助金额:
$ 33.76万 - 项目类别:
Regulation of Medulloblastoma Metastasis by Emp1
Emp1 对髓母细胞瘤转移的调节
- 批准号:
9222061 - 财政年份:2016
- 资助金额:
$ 33.76万 - 项目类别:
Stem Cells, Progenitors, and the Origin of Medulloblastoma
干细胞、祖细胞和髓母细胞瘤的起源
- 批准号:
8244482 - 财政年份:2009
- 资助金额:
$ 33.76万 - 项目类别:
IMAGING OF PRE-NEOPLASTIC LESIONS IN A MOUSE MODEL OF MEDULLOBLASTOMA
髓母细胞瘤小鼠模型中肿瘤前病变的成像
- 批准号:
7956907 - 财政年份:2009
- 资助金额:
$ 33.76万 - 项目类别:
Stem Cells, Progenitors, and the Origin of Medulloblastoma
干细胞、祖细胞和髓母细胞瘤的起源
- 批准号:
7798066 - 财政年份:2009
- 资助金额:
$ 33.76万 - 项目类别:
Identification of a Mitogen for Neuronal Progenitors in the Embryonic Cerebellum
胚胎小脑神经元祖细胞有丝分裂原的鉴定
- 批准号:
7932829 - 财政年份:2009
- 资助金额:
$ 33.76万 - 项目类别:
Stem Cells, Progenitors, and the Origin of Medulloblastoma
干细胞、祖细胞和髓母细胞瘤的起源
- 批准号:
8446152 - 财政年份:2009
- 资助金额:
$ 33.76万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 33.76万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 33.76万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 33.76万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 33.76万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 33.76万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 33.76万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 33.76万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 33.76万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 33.76万 - 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
- 批准号:
10762827 - 财政年份:2023
- 资助金额:
$ 33.76万 - 项目类别:














{{item.name}}会员




